Thorac Cardiovasc Surg 2017; 65(06): 473
DOI: 10.1055/s-0036-1597595
Letter to the Editor
Georg Thieme Verlag KG Stuttgart · New York

Atrioesophageal Fistula after Minimally Invasive Video-Assisted Epicardial Ablation Reported by Kik

Piotr Suwalski
1  Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland
› Institutsangaben
Weitere Informationen


19. Oktober 2016

07. November 2016

09. Januar 2017 (online)

“Reply by the Authors of the Original Article”

I would like to share my comments regarding the Short Communication report “Atrioesophageal Fistula after Minimally Invasive Video-Assisted Epicardial Ablation for Lone Atrial Fibrillation” by Kik et al published in the recent Thoracic and Cardiovascular Surgeon (DOI:; ISSN: 0171–6425). The authors report on three fistulae following the thoracoscopic bilateral epicardial ablation of atrial fibrillation (AF) using the AtriCure system.

We have been involved in the minimally invasive AF ablation procedures for more than 12 years and performed few hundreds of them using practically all devices that have been introduced in the market during that time, and in the past 6 years we have been performing regularly the depicted kind of procedure as a teaching center. The occurrence of three atrio-esophageal fistulas (AEFs) in one center within relatively short time frame should raise concern, especially in a procedure that is very well validated and standardized over the past decade. Unfortunately, I am not aware of the team's experience. From the technical point of view, knowing the technical features of the system it is difficult to understand the surgical mechanism behind it. The system is based on the bipolar/transpolar energy delivery with the current transmission only between the electrodes located within the device (no zero electrode), and the active side of the device is clearly indicated by its construction. The procedure is thoracoscopically easily controlled and the only way of injuring the esophagus would be by facing the active side toward it, which should not be treated as the system or procedure failure. The applicator is touched epicardially under vision to the atrium and pushed gently against it away from adjacent tissues under electronic generator unit control showing the current adherence. Every ablating system has naturally its strong and weak points, but in terms of AEF creation the system construction belongs to the safest. As mentioned earlier, the procedure is very well evaluated and standardized over the past decade, with few thousands of cases published from all over the world, including prospective controlled randomized trials, meta-analyses, and also personal communication, revealing no complication such as this.[1] [2] [3]